Retrophin (RTRX) Misses Q2 EPS by 21c, Miss on Revenues

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. SPY
9. XYZ
10. CVS

Go back to Retrophin (RTRX) Misses Q2 EPS by 21c, Miss on Revenues

Retrophin Reports Second Quarter 2018 Financial Results and Announces CEO Transition Plan

July 26, 2018 4:05 PM EDT

Patients continue to enroll in Phase 3 FORT Study of fosmetpantotenate in PKAN and Phase 3 DUPLEX Study of sparsentan in FSGS

Phase 2 proof-of-concept study of CNSA-001 in patients with PKU set to initiate; top-line results expected in early 2019

Retrophin Chief Executive Officer Stephen Aselage announces his decision to retire; Board of Directors initiates search for successor

SAN DIEGO, July 26, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today reported its second quarter 2018 financial results and provided a corporate update.

In... More